Baku 4° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
14:57
Azerbaijan offers to share advanced agricultural expertise with Ghana
AIC14:55
Pakistani PM thanks Azerbaijan for support in launching ASAN Service center
Foreign policy14:54
Hakan Fidan: Ensuring peace in South Caucasus remained Türkiye's priority in 2025
Region14:30
Non-immigrant visas continue to be processed at US Embassy in Baku
Foreign policy14:22
Armenia awaits Russia's decision on restoring railway lines to borders with Azerbaijan, Türkiye
Foreign policy14:08
Türkiye to deploy jets to Estonia, Romania under NATO air policing missions
Region14:01
Turkish FM: Iran should avoid actions that may endanger region
Region13:44
Türkiye, US discuss Iran and Syria developments in Ankara meeting
Region13:35